Pre-Open Stock Movers 05/12: (LHDX) (UPST) (EYES) Higher; (ARRY) (CURI) (LMND) Lower (more...)

May 12, 2021 9:26 AM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Today's Pre-Open Movers:

Lucira Health, Inc. (Nasdaq: LHDX) 40.9% HIGHER; announced that its LUCIRA CHECK IT COVID-19 test kit is now available on Amazon.com in the US. Each LUCIRA CHECK IT test kit provides a PCR quality test result at home in 30 minutes or less. After testing, users can also receive a free, text based digital LUCI PASS verified test result on their phone for work or travel. The product costs $55 and includes free standard shipping.

Upstart Holdings (NASDAQ: UPST) 27.7% HIGHER; reported Q1 EPS of $0.11, $0.04 worse than the analyst estimate of $0.15. Revenue for the quarter came in at $121.3 million versus the consensus estimate of $116.06 million. Upstart Holdings sees FY2021 revenue of $150-160 million, versus the consensus of $117.1 million. Adjusted EBITDA of $23 to $27 million.

Array Technologies Inc. (NASDAQ: ARRY) 26.1% LOWER; reported Q1 EPS of $0.19, $0.01 worse than the analyst estimate of $0.20. Revenue for the quarter came in at $245.9 million versus the consensus estimate of $240.83 million.

Second Sight Medical Products, Inc. (NASDAQ: EYES) 21.8% HIGHER; announced two-year results of its Early Feasibility Study (Study) of the Orion Visual Cortical Prosthesis (Orion). The Study is a single arm six subject study at UCLA and Baylor College of Medicine. The Study was paused due to the COVID-19 pandemic, but is now resumed at both centers. All subjects are still enrolled in the Study and recent visual function and functional vision results continue to demonstrate that a majority of participants benefit from Orion. Five out of five of those tested at the two-year mark are able to locate a white square on a dark computer screen significantly better with the Orion System on than with it off. Four out of five of those tested at the two-year mark are able to better identify the direction of motion of a bar moving across a computer screen with the Orion System on. The Functional Low-Vision Observer Rated Assessment (FLORA) has only been performed with two subjects due to COVID-19 travel restrictions, but both were rated as receiving mild positive or positive benefit from the Orion in real-world settings. The remaining 24-month visits are currently being scheduled. There has been only one serious adverse event early in the Study. The event was completely resolved without hospitalization.

fuboTV Inc. (NYSE: FUBO) 18.2% HIGHER; reported Q1 EPS of ($0.55), $0.09 worse than the analyst estimate of ($0.46). Revenue for the quarter came in at $119.7 million versus the consensus estimate of $103.88 million. fuboTV Inc. sees Q2 2021 revenue of $120-122 million, versus the consensus of $98.4 million. fuboTV Inc. sees FY2021 revenue of $520-530 million, versus the consensus of $472.6 million.

CuriosityStream Inc. (NASDAQ: CURI) 14.3% LOWER; reported Q1 EPS of ($0.39), $0.07 worse than the analyst estimate of ($0.32). Revenue for the quarter came in at $9.9 million versus the consensus estimate of $11.36 million. CuriosityStream Inc. sees FY2021 revenue of at least $71 million, versus the consensus of $71.14 million.

Lumentum Holdings (NASDAQ: LITE) 9.9% LOWER; reported Q3 EPS of $1.40, in-line with the analyst estimate of $1.40. Revenue for the quarter came in at $419.5 million versus the consensus estimate of $433.49 million. Lumentum Holdings sees Q4 2021 EPS of $0.92-$1.14, versus the consensus of $1.26. Lumentum Holdings sees Q4 2021 revenue of $360-400 million, versus the consensus of $408.97 million.

Lemonade (NYSE: LMND) 9.4% LOWER; reported Q1 EPS of ($0.81), in-line with the analyst estimate of ($0.81). Revenue for the quarter came in at $23.5 million versus the consensus estimate of $22 million. Lemonade sees Q2 2021 revenue of $26-27 million, versus the consensus of $26.24 million. Lemonade sees FY2021 revenue of $117-120 million, versus the consensus of $115.56 million.

SelectQuote, Inc. (NYSE: SLQT) 8.9% LOWER; reported Q3 EPS of $0.22, $0.01 worse than the analyst estimate of $0.23. Revenue for the quarter came in at $266.9 million versus the consensus estimate of $261.06 million. SelectQuote, Inc. sees FY2021 revenue of $920-940 million, versus the consensus of $934.91 million.

ShotSpotter, Inc. (NASDAQ: SSTI) 8.8% HIGHER; Q1 revenues increased 44% to $15.0 million from $10.5 million for the first quarter of 2020

Grocery Outlet Holding Corp. (NASDAQ: GO) 7.3% LOWER; reported Q1 EPS of $0.19, $0.03 worse than the analyst estimate of $0.22. Revenue for the quarter came in at $752.5 million versus the consensus estimate of $757.63 million.

VIZIO Holding Corp. (NYSE: VZIO) 6.2% LOWER; reported Q1 EPS of $0.02, $0.12 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $505.7 million versus the consensus estimate of $484.07 million.

Wendy's (NASDAQ: WEN) 4.6% HIGHER; reported Q1 EPS of $0.20, $0.06 better than the analyst estimate of $0.14. Revenue for the quarter came in at $460.2 million versus the consensus estimate of $444.31 million. Wendy's sees FY2021 EPS of $0.72-$0.74, versus the consensus of $0.69.

Axonics, Inc. (Nasdaq: AXNX) 4.5% LOWER; announced that it has commenced a proposed public offering of $150,000,000 in shares of its common stock.

QuantumScape (NYSE: QS) 3.7% LOWER; reported Q1 EPS of ($0.20), $0.13 worse than the analyst estimate of ($0.07).



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Special Reports

Related Entities

Pre-Open Losers, Pre-Open Winners, Pre Market Movers